Literature DB >> 23294849

Intramuscular transplantation of myogenic cells in primates: importance of needle size, cell number, and injection volume.

Daniel Skuk1, Marlyne Goulet, Jacques P Tremblay.   

Abstract

The aim of this study was to quantitatively define the main measurable technical parameters for the intramuscular transplantation of myogenic cells in primates. Myoblasts transduced with the gene coding for β-galactosidase were injected into the skeletal muscles of 15 monkeys. The following parameters were studied: needle size, number of cells per injection, and volume of cell suspension per injection. Monkeys were immunosuppressed with tacrolimus. The cell-injected sites were biopsied 1 or 2 months later. Biopsies were examined histologically to assess the myoblast engraftment and the muscle structure. The conclusions were as follows: (1) Needles should be thin enough to avoid important tissue damage and allow muscle regeneration as satisfactory as possible. Among those tested, 27G should be the choice if the length is consistent with depth of injection. (2) At least 100,000 cells should be delivered per centimeter of needle trajectory. (3) The smallest volumes of cell suspension per injection should be used. In this study, 1 µl/cm of injection trajectory was sufficient. In principle, these parameters apply to muscles in which no damage occurred other than the injections.

Entities:  

Mesh:

Year:  2013        PMID: 23294849     DOI: 10.3727/096368912X661337

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  16 in total

Review 1.  Therapies for sarcopenia and regeneration of old skeletal muscles: more a case of old tissue architecture than old stem cells.

Authors:  Miranda D Grounds
Journal:  Bioarchitecture       Date:  2014-07-28

2.  Clarifying misconceptions about myoblast transplantation in myology.

Authors:  Daniel Skuk; Jacques P Tremblay
Journal:  Mol Ther       Date:  2014-05       Impact factor: 11.454

Review 3.  Stem cell therapy for muscular dystrophies.

Authors:  Stefano Biressi; Antonio Filareto; Thomas A Rando
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

4.  Plasmonic fusion between fibroblasts and skeletal muscle cells for skeletal muscle regeneration.

Authors:  Limor Minai; Dvir Yelin
Journal:  Biomed Opt Express       Date:  2022-01-06       Impact factor: 3.732

Review 5.  Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal Muscle.

Authors:  Olivier Boyer; Gillian Butler-Browne; Hector Chinoy; Giulio Cossu; Francesco Galli; James B Lilleker; Alessandro Magli; Vincent Mouly; Rita C R Perlingeiro; Stefano C Previtali; Maurilio Sampaolesi; Hubert Smeets; Verena Schoewel-Wolf; Simone Spuler; Yvan Torrente; Florence Van Tienen
Journal:  Front Genet       Date:  2021-08-02       Impact factor: 4.599

6.  Optimized lentiviral vector to restore full-length dystrophin via a cell-mediated approach in a mouse model of Duchenne muscular dystrophy.

Authors:  Jinhong Meng; Marc Moore; John Counsell; Francesco Muntoni; Linda Popplewell; Jennifer Morgan
Journal:  Mol Ther Methods Clin Dev       Date:  2022-05-02       Impact factor: 5.849

Review 7.  Hydrogel biomaterials and their therapeutic potential for muscle injuries and muscular dystrophies.

Authors:  Rachel Lev; Dror Seliktar
Journal:  J R Soc Interface       Date:  2018-01       Impact factor: 4.118

Review 8.  Generation of skeletal muscle cells from pluripotent stem cells: advances and challenges.

Authors:  Ramzey Abujarour; Bahram Valamehr
Journal:  Front Cell Dev Biol       Date:  2015-05-13

9.  Myogenic progenitor cell transplantation for muscle regeneration following hindlimb ischemia and reperfusion.

Authors:  Franka Messner; Marco Thurner; Stefan Schneeberger; Theresa Hautz; Jule Müller; Michael Blumer; Julia Hofmann; Rainer Marksteiner; Sebastien Couillard-Despres; Jakob Troppmair; Dietmar Öfner
Journal:  Stem Cell Res Ther       Date:  2021-02-24       Impact factor: 6.832

Review 10.  Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy.

Authors:  Serge Ostrovidov; Xuetao Shi; Ramin Banan Sadeghian; Sahar Salehi; Toshinori Fujie; Hojae Bae; Murugan Ramalingam; Ali Khademhosseini
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 6.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.